700 related articles for article (PubMed ID: 31810731)
1. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
[TBL] [Abstract][Full Text] [Related]
2. Canadian-Australasian Randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study.
Ying T; Gill J; Webster A; Kim SJ; Morton R; Klarenbach SW; Kelly P; Ramsay T; Knoll GA; Pilmore H; Hughes G; Herzog CA; Chadban S; Gill JS
Am Heart J; 2019 Aug; 214():175-183. PubMed ID: 31228771
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management.
Minami HR; Itoga NK; George EL; Garcia-Toca M
J Vasc Surg; 2021 Dec; 74(6):2030-2039.e2. PubMed ID: 34175383
[TBL] [Abstract][Full Text] [Related]
4. A Markov Analysis of Screening for Late-Onset Cytomegalovirus Disease in Cytomegalovirus High-Risk Kidney Transplant Recipients.
Puttarajappa CM; Hariharan S; Smith KJ
Clin J Am Soc Nephrol; 2018 Feb; 13(2):290-298. PubMed ID: 29025787
[TBL] [Abstract][Full Text] [Related]
5. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of coronary artery disease screening in HIV-infected men.
Nolte JE; Neumann T; Manne JM; Lo J; Neumann A; Mostardt S; Abbara S; Hoffmann U; Brady TJ; Wasem J; Grinspoon SK; Gazelle GS; Goehler A
Eur J Prev Cardiol; 2014 Aug; 21(8):972-9. PubMed ID: 23539717
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
[TBL] [Abstract][Full Text] [Related]
9. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant.
Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC
Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812
[TBL] [Abstract][Full Text] [Related]
10. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
[TBL] [Abstract][Full Text] [Related]
12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.
Vegter S; Tolley K; Keith MS; Lok CE; Soroka SD; Morton AR
Clin Ther; 2012 Jul; 34(7):1531-43. PubMed ID: 22742885
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
15. Health economic evaluation of rivaroxaban in the treatment of patients with chronic coronary artery disease or peripheral artery disease.
Cowie MR; Lamy A; Levy P; Mealing S; Millier A; Mernagh P; Cristeau O; Bowrin K; Briere JB
Cardiovasc Res; 2020 Sep; 116(11):1918-1924. PubMed ID: 31807773
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Mealing S; Roome C; Snaith A; D'Souza R; Welch K; Stein K
Health Technol Assess; 2007 May; 11(18):iii, xi-xiii, 1-167. PubMed ID: 17462168
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of sevelamer in patients with end-stage renal disease.
Manns B; Klarenbach S; Lee H; Culleton B; Shrive F; Tonelli M
Nephrol Dial Transplant; 2007 Oct; 22(10):2867-78. PubMed ID: 17595182
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.
van Kempen BJ; Spronk S; Koller MT; Elias-Smale SE; Fleischmann KE; Ikram MA; Krestin GP; Hofman A; Witteman JC; Hunink MG
J Am Coll Cardiol; 2011 Oct; 58(16):1690-701. PubMed ID: 21982314
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
Ito K
JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
